Discover 1,559 paid clinical trials in Arizona. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.
Sponsor:
Corbus Pharmaceuticals Inc.
Location:
Code:
NCT06603844
Conditions
Solid Tumor
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
CRB-601 monoclonal antibody
Anti-PD-1 monoclonal antibody
Immune-priming single lesion SBRT
Sponsor:
Processa Pharmaceuticals
Location:
Code:
NCT06568692
Conditions
Breast Cancer
TNBC - Triple-Negative Breast Cancer
HER2-negative Breast Cancer
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
PCS6422 and capecitabine
Capecitabine
Sponsor:
Eli Lilly and Company
Location:
Code:
NCT05986292
Conditions
Osteoarthritis, Knee
Diabetic Neuropathic Pain
Chronic Low-back Pain
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
LY3016859 ISA
LY3556050 ISA
LY3526318 ISA
LY3857210 ISA
Placebo Oral
Sponsor:
Alexion Pharmaceuticals, Inc.
Location:
Code:
NCT06291376
Conditions
Immunoglobulin A Nephropathy
IgAN
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Ravulizumab
Placebo
Sponsor:
RayzeBio, Inc.
Location:
Code:
NCT05477576
Conditions
GEP-NET
Gastroenteropancreatic Neuroendocrine Tumor
Gastroenteropancreatic Neuroendocrine Tumor Disease
Neuroendocrine Tumors
Carcinoid
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
RYZ101
Everolimus
Sunitinib
Octreotide
Lanreotide
Sponsor:
AbbVie
Location:
Code:
NCT04777994
Conditions
Advanced Solid Tumor Cancer
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
ABBV-CLS-484
Vascular Endothelial Growth Factor Receptor (VEGFR) Tyrosine Kinase Inhibitor (TKI)
Programmed Cell Death-1 (PD-1) Inhibitor
Sponsor:
Novo Nordisk A/S
Location:
Code:
NCT05636176
Conditions
Heart Failure
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Ziltivekimab
Placebo
Sponsor:
University of Pittsburgh
Location:
Code:
NCT05172089
Conditions
Chronic Wounds
Biofilm Infection
Trans-epidermal Water Loss (TEWL)
Diabetic Foot
Diabetic Foot Infection
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Sponsor:
MoonLake Immunotherapeutics AG
Location:
Code:
NCT06641089
Conditions
Arthritis, Psoriatic
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Sonelokimab
Placebo
Risankizumab
Sponsor:
Merck Sharp & Dohme LLC
Location:
Code:
NCT06469944
Conditions
Gastroesophageal Junction
Gastroesophageal Adenocarcinoma
Esophageal Neoplasms
Esophageal Cancer
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Pembrolizumab
Sacituzumab Tirumotecan (sac-TMT)
Capecitabine
Leucovorin
Levoleucovorin
With a diverse healthcare network and renowned medical research institutions, Arizona is a key player in clinical research. Leading clinical research organizations such as the Mayo Clinic in Phoenix, Banner Health, University of Arizona Health Sciences, and the Translational Genomics Research Institute (TGen) are driving medical research and innovation advancements. These institutions are at the forefront of clinical studies, contributing significantly to cutting-edge treatments and healthcare advancements across the state.
Participating in clinical trials in Arizona offers several unique advantages. First, due to the state being home to some of the nation's top research institutions, participants have access to cutting-edge treatments and advanced medical care. These institutions are leaders in fields like oncology, cardiology, and precision medicine, allowing participants to be at the forefront of groundbreaking medical advancements.
Another significant advantage is Arizona's diverse population, which allows for a broad range of clinical trials addressing different demographics and health conditions. This diversity increases the relevance of clinical trial outcomes across varied populations, ensuring more accurate and inclusive medical research. Additionally, Arizona’s pleasant climate and growing healthcare infrastructure make participation in trials more convenient and accessible, especially for those traveling to Phoenix or Tucson for care.
In Arizona, clinical trials commonly focus on conditions that are prevalent in the state and the broader U.S. Southwest region.
Arizona has a higher-than-average prevalence of diabetes, particularly among its Native American and Hispanic populations. Clinical trials in this area focus on new medications, lifestyle interventions, self-management, holistic therapies, and technologies like insulin delivery systems.
Several research institutions in Arizona are currently carrying out clinical trials for diabetes including the Mayo Clinic, Banner Health, and the Phoenix Indian Medical Center. The University of Arizona Health Sciences in Tucson also plays a significant role in diabetes research. Through its partnerships with the College of Medicine, College of Pharmacy, and other departments, UAHS is involved in clinical trials and research initiatives targeting type 1, type 2, and gestational diabetes.
With renowned research institutions like the Mayo Clinic and the University of Arizona Cancer Center, oncology is a major focus for clinical research teams in Arizona. Researchers study a wide range of cancers here, including breast, lung, skin (melanoma), and prostate cancers, among others. Arizona’s aging population makes cancer research especially relevant.
Oncology clinical trials in Arizona offer access to innovative treatments for participants, such as new medications, immunotherapies, and advanced treatment techniques that are not yet widely available.
Interested in learning more about how clinical trials for cancer work? Explore our guide to better understand oncology clinical trials and how they contribute to advancing cancer treatments.
Given Arizona’s dry climate and high levels of dust and pollen, respiratory conditions like asthma, chronic obstructive pulmonary disease (COPD), and valley fever (coccidioidomycosis) are also frequently studied in clinical trials. With its unique environment and healthcare infrastructure, Arizona is an important hub for respiratory disease research.
Heart disease is the leading cause of death in Arizona, meaning the state places a large emphasis on clinical research trials for cardiovascular conditions. These often explore innovative treatments for conditions such as heart failure, hypertension, and atrial fibrillation.
Institutions like the Banner University Medical Center and the Arizona Heart Institute are committed to improving preventative measures for this prevalent condition, as well as developing new treatments to combat it. The main goal of many research trials here is to reduce the impact of cardiovascular disease on millions of Arizona residents, as well as the wider population.
Current innovations being tested in Arizona include gene therapy, regenerative medicine, stem cell therapy, minimally invasive valve replacement, and advanced medical devices for heart failure.
Conditions such as Alzheimer's disease, Parkinson's disease, strokes, and multiple sclerosis (MS) are also common areas of study in Arizona. The state is home to research centers like Barrow Neurological Institute, which is one of the world’s leading centers for research and treatment of neurological conditions. This center leads clinical trials on treatments and therapies for these diseases and is also known for its advanced surgical treatments.
Several key innovations in neurological disorders are currently being tested in clinical trials in Arizona, including gene therapy, precision medicine, stem cell therapy, deep brain stimulation, immunotherapy, wearable devices, and regenerative medicine. These cutting-edge approaches aim to improve diagnosis, treatment, and overall quality of life for patients.
Clinical trials in Arizona are governed by a combination of federal, state, and local regulations designed to ensure the safety, ethical treatment, and privacy of participants. While Arizona’s clinical trial regulations mostly follow federal guidelines, there are also some state-specific considerations including informed consent for minors and vulnerable populations, medical marijuana research guidelines, and pharmacy board oversight.
Before any clinical trial can commence in Arizona, it must be reviewed and approved by an Institutional Review Board (IRB). IRBs must ensure clinical trials meet ethical standards and comply with federal and state regulations, including gaining informed consent, maintaining confidentiality, and monitoring participant safety. Clinical trials conducted in Arizona are also often required to be registered with ClinicalTrials.gov, a federal database where trial protocols and results are publicly accessible.
Joining a clinical trial provides a range of advantages, such as the opportunity to receive innovative treatments and therapies before they are widely accessible. Participants benefit from close supervision by leading healthcare professionals who offer specialized attention and care throughout the study.
Furthermore, taking part in clinical trials helps drive crucial medical research that could lead to new breakthroughs in treatment for future patients. By participating, individuals not only gain early exposure to cutting-edge medical options but also contribute to the progress of science, helping to improve healthcare for others.
Enrolling in a clinical trial through our platform is a straightforward and user-friendly process. Here's how to get started: